C69.52 - Malignant neoplasm of left lacrimal gland and duct

Version 2023
ICD-10:C69.52
Short Description:Malignant neoplasm of left lacrimal gland and duct
Long Description:Malignant neoplasm of left lacrimal gland and duct
Status: Valid for Submission
Version:ICD-10-CM 2023
Code Classification:
  • Neoplasms (C00–D48)
    • Malignant neoplasms of eye, brain and other parts of central nervous system (C69-C72)
      • Malignant neoplasm of eye and adnexa (C69)

C69.52 is a billable ICD-10 code used to specify a medical diagnosis of malignant neoplasm of left lacrimal gland and duct. The code is valid during the fiscal year 2023 from October 01, 2022 through September 30, 2023 for the submission of HIPAA-covered transactions.

The following anatomical sites found in the Table of Neoplasms reference the parent code C69.5 of the current diagnosis code given the correct histological behavior: Neoplasm, neoplastic lacrimal ; Neoplasm, neoplastic lacrimal canaliculi ; Neoplasm, neoplastic lacrimal duct (nasal) ; Neoplasm, neoplastic lacrimal gland ; Neoplasm, neoplastic lacrimal punctum ; Neoplasm, neoplastic lacrimal sac ; Neoplasm, neoplastic nasolacrimal duct ; etc

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

Convert to ICD-9 Code

Source ICD-10 CodeTarget ICD-9 Code
C69.52190.2 - Mal neo lacrimal gland
Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.
C69.52190.7 - Mal neo lacrimal duct
Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.

Table of Neoplasms

The parent code C69.5 of the current diagnosis code is referenced in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»Neoplasm, neoplastic
  »lacrimal
C69.5C79.49D09.2D31.5D48.7D49.89
»Neoplasm, neoplastic
  »lacrimal
    »canaliculi
C69.5C79.49D09.2D31.5D48.7D49.89
»Neoplasm, neoplastic
  »lacrimal
    »duct (nasal)
C69.5C79.49D09.2D31.5D48.7D49.89
»Neoplasm, neoplastic
  »lacrimal
    »gland
C69.5C79.49D09.2D31.5D48.7D49.89
»Neoplasm, neoplastic
  »lacrimal
    »punctum
C69.5C79.49D09.2D31.5D48.7D49.89
»Neoplasm, neoplastic
  »lacrimal
    »sac
C69.5C79.49D09.2D31.5D48.7D49.89
»Neoplasm, neoplastic
  »nasolacrimal duct
C69.5C79.49D09.2D31.5D48.7D49.89

Patient Education


Eye Cancer

Cancer of the eye is uncommon. It can affect the outer parts of the eye, such as the eyelid, which are made up of muscles, skin and nerves. If the cancer starts inside the eyeball it's called intraocular cancer. The most common intraocular cancers in adults are melanoma and lymphoma. The most common eye cancer in children is retinoblastoma, which starts in the cells of the retina. Cancer can also spread to the eye from other parts of the body.

Treatment for eye cancer varies by the type and by how advanced it is. It may include surgery, radiation therapy, freezing or heat therapy, or laser therapy.


[Learn More in MedlinePlus]

Code History